Lv11
30 积分 2024-05-18 加入
Beneficial effects of brown fat activation on top of PCSK9 inhibition with alirocumab on dyslipidemia and atherosclerosis development in APOE*3-Leiden.CETP mice
12小时前
待确认
TET2-Driven Clonal Hematopoiesis and Response to Canakinumab
12小时前
已完结
Distribution of human plasma PLTP mass and activity in hypo- and hyperalphalipoproteinemia
27天前
已完结
Quantification of human plasma phospholipid transfer protein (PLTP): relationship between PLTP mass and phospholipid transfer activity
27天前
已完结
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
2个月前
已完结
ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction
3个月前
已完结
Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)
3个月前
已完结
Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial
3个月前
已完结
Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome
4个月前
已完结
Plasma pre β-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein
4个月前
已完结
皖公网安备34019202002308
